Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate and brain dopamine neurotoxicity

J Yuan1, U McCann, G Ricaurte

  • 1Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.

Brain Research
|August 29, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anomalous magnetoresistance in the spinel superconductor LiTi2O4.

Nature communications·2015
Same author

Kinematic HAADF-STEM image simulation of small nanoparticles.

Micron (Oxford, England : 1993)·2015
Same author

ZnRF3 induces apoptosis of gastric cancer cells by antagonizing Wnt and Hedgehog signaling.

Panminerva medica·2015
Same author

MicroRNA-494 promotes cyclosporine-induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Cohn process influences the functional anticoagulant activity of human protein C.

Genetics and molecular research : GMR·2015
Same author

Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015

Methylphenidate, unlike amphetamine, does not appear to cause dopamine neurotoxicity. This study suggests amphetamine neurotoxicity findings may be misleading with short survival periods.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Methylphenidate is a widely prescribed psychostimulant.
  • The dopamine (DA) neurotoxic potential of methylphenidate requires further evaluation.
  • Amphetamine is known to cause DA neurotoxicity.

Purpose of the Study:

  • To compare the dopamine neurotoxic potential of methylphenidate and amphetamine in mice.
  • To investigate the dose and treatment schedule effects of methylphenidate on DA axonal markers.
  • To assess the influence of survival period on the interpretation of neurotoxicity studies.

Main Methods:

  • Mice were administered varying doses and schedules of methylphenidate.
  • Dopamine axonal markers in the striatum were measured.

Related Experiment Videos

  • Behavioral effects, including stereotypy, were observed.
  • Comparison was made with amphetamine treatment effects.

    • Main Results:

    • Higher methylphenidate doses induced intense stereotypy and short-term (5-day) depletions of striatal DA axonal markers, but not long-term (2-week) depletions.
    • Amphetamine induced intense stereotypy and profound, long-lasting, dose-related DA deficits.
    • Short-term (5-day) post-drug survival periods may be misleading for amphetamine neurotoxicity studies.

    Conclusions:

    • Methylphenidate lacks significant dopamine neurotoxic potential, unlike amphetamine.
    • Dopamine efflux is necessary but not sufficient for amphetamine-induced DA neurotoxicity.
    • Findings confirm and extend previous research on methylphenidate's safety profile regarding DA neurotoxicity.